EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches

Sara Aiman, Abbas Ahmad, Asifullah Khan iD, Yasir Ali iD, Abdul Malik, Musaed Alkholief, Suhail Akhtar, Raham Sher Khan, Chunhua Li, Fazal Jalil, Yasir Ali iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0289773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Sara Aiman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing, China. Hauptthemen laut MEDLINE: Shigella sonnei, Dysentery, Bacillary. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shigella sonnei is a gram-negative bacterium and is the primary cause of shigellosis in advanced countries. An exceptional rise in the prevalence of the disease has been reported in Asia, the Middle East, and Latin America. To date, no preventive vaccine is available against S . sonnei infections. This pathogen has shown resistances towards both first- and second-line antibiotics. Therefore, an effective broad spectrum vaccine development against shigellosis is indispensable. In the present study, vaccinomics-aided immunoinformatics strategies were pursued to identify potential vaccine candidates from the S . sonnei whole proteome data. Pathogen essential proteins that are non-homologous to human and human gut microbiome proteome set, are feasible candidates for this purpose. Three antigenic outer membrane proteins were prioritized to predict lead epitopes based on reverse vaccinology approach. Multi-epitope-based chimeric vaccines was designed using lead B- and T-cell epitopes combined with suitable linker and adjuvant peptide sequences to enhance immune responses against the designed vaccine. The SS-MEVC construct was prioritized based on multiple physicochemical, immunological properties, and immune-receptors docking scores. Immune simulation analysis predicted strong immunogenic response capability of the designed vaccine construct. The Molecular dynamic simulations analysis ensured stable molecular interactions of lead vaccine construct with the host receptors. In silico restriction and cloning analysis predicted feasible cloning capability of the SS-MEVC construct within the E . coli expression system. The proposed vaccine construct is predicted to be more safe, effective and capable of inducing robust immune responses against S . sonnei infections and may be worthy of examination via in vitro / in vivo assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shigella sonneiDysentery, BacillaryHumansProteomeEscherichia coliCheminformaticsMolecular Docking SimulationBacterial VaccinesVaccines, SubunitEpitopes, T-LymphocyteMolecular Dynamics SimulationComputational BiologyEpitopes, B-Lymphocyte

Substanzen

ProteomeBacterial VaccinesVaccines, SubunitEpitopes, T-LymphocyteEpitopes, B-Lymphocyte

Autor:innen und Institutionen

  • Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing, China.
  • Department of Biotechnology, Abdul Wali Khan University Mardan, Khyber Pakhtunkhwa, Pakistan.
  • Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan, Khyber Pakhtunkhwa, Pakistan.
  • National Center for Bioinformatics, Quaid-i-Azam University Islamabad, Islamabad, Pakistan.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • A.T. Still University of Health Sciences, Kirksville, Missouri, United States of America.

ORCID-Profile: Asifullah Khan, Yasir Ali, Yasir Ali

Förderung

  • King Saud University
  • National Natural Science Foundation of China

Zitieren

APA

Aiman, S., Ahmad, A., Khan, A., Ali, Y., Malik, A., Alkholief, M., Akhtar, S., Khan, R. S., Li, C., Jalil, F., & Ali, Y. (2023). Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches. PLOS ONE. https://doi.org/10.1371/journal.pone.0289773

Vancouver

Aiman S, Ahmad A, Khan A, Ali Y, Malik A, Alkholief M, et al. Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches. PLOS ONE. 2023. doi:10.1371/journal.pone.0289773

BibTeX
@article{Aiman2023,
  author = {Aiman, Sara and Ahmad, Abbas and Khan, Asifullah and Ali, Yasir and Malik, Abdul and Alkholief, Musaed and Akhtar, Suhail and Khan, Raham Sher and Li, Chunhua and Jalil, Fazal and Ali, Yasir},
  title = {Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0289773}
}
Kostenlos starten →